HSBC Holdings
LAB icon

HSBC Holdings’s Standard BioTools LAB Stock Holding History

HSBC Holdings’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219K Buy
+271,523
New +$257K ﹤0.01% 2661
2025
Q4 		– Sell
-45,685
Closed -$59.2K – 3060
2025
Q3 		$59.2K Sell
45,685
-10,492
-19% -$13.7K ﹤0.01% 2638
2025
Q2 		$67.1K Sell
56,177
-23,595
-30% -$26.2K ﹤0.01% 2906
2025
Q1 		$85.8K Sell
79,772
-225
-0.3% -$316 ﹤0.01% 2841
2024
Q4 		$139K Sell
79,997
-2,613
-3% -$4.87K ﹤0.01% 2818
2024
Q3 		$157K Buy
82,610
+33,609
+69% +$65.8K ﹤0.01% 2700
2024
Q2 		$88.9K Hold
49,001
– – ﹤0.01% 2754
2024
Q1 		$133K Buy
+49,001
New +$118K ﹤0.01% 2780
2019
Q3 		– Sell
-107,183
Closed -$1.32M – 3109
2019
Q2 		$1.32M Buy
+107,183
New +$1.37M ﹤0.01% 1677

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

HSBC Holdings's LAB Position: Q2 2026 in Review

HSBC Holdings opened a new position in Standard BioTools (LAB) in Q2 2026: 271,523 shares worth $219K. The stake represents ﹤0.01% of the portfolio and ranks #2661 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in LAB as recently as Q3 2025.

HSBC Holdings first reported a position in LAB in Q2 2019 and has held it in 9 quarters since. The position peaked at $1.32M in Q2 2019. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • HSBC Holdings held 271,523 shares of Standard BioTools worth $219K as of Q2 2026.
  • Standard BioTools was a new HSBC Holdings position in Q2 2026.
  • Standard BioTools made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2661 holding.
  • HSBC Holdings first reported a position in Standard BioTools in Q2 2019 and has held it in 9 quarters since.
  • HSBC Holdings's Standard BioTools position peaked at $1.32M in Q2 2019.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.